anti-arrythmics + anti-angina + cardiac glycosides Flashcards
what is a non-pacemaker blockade
suppress abnormal atrial or ventricular cells to restore normal sinus rhythm (RHYTHM control)
- Na channel blocker and potassium channel blocker
what is an AVN blockade
suppress AV node to prevent high atrial rate from causing high ventricular rate (RATE control)
- beta blocker and calcium channel blocker
types of sodium channel blocker
increasing degree of blockade of Na channel: B,A,C
MOA of Class 1C Na channel blocker
eg flerainide
MOA: slows phase 0 depolarisation
use: refractory ventricular tachycardia
1C=no change
MOA of Class 1A Na channel blocker
eg procainamide
MOA: slow phase 0 depolarisation
prolonged effective refractory period (moment cell starts repolarising) and action potential duration becase drug has K channel blockade
1A = after = prolong AP
MOA of CLass 1B Na channel blocker
eg lidocaine
MOA : slow phase 0 depolarisation and shorten phase 3 repolarisation
decrease action potential duration but ERP unchanged
1B=before=shorten AP
MOA of K channel blocker
eg SAD
Sotalol
Amiodarone
Dofelitide
MOA: slow down phase 3 repolarisation -> increase ERP and APD
use of K channel blocker
- atrial fibrillation
- prevent reentrant ventricular tachycardia => instead of completing normal circuit, electrical signal has alt loop back upon itself (self perpetuating rapid and abnormal activation)
special quality about K channel blocker
Amiodarone is metabolised by liver into active metabolites
this means that effect persist even after discontinuation of the drug (long half life: effect maintained 1-3mths after discontinuation)
MOA of beta blockers
block binding of NE to beta receptor so voltage gated Ca channels cannot open and calcium cannot enter
reduced slope of 4 (depolarisation to threshold potential and slope of 0 (when calcium channels supposed to open)
takes longer time before can depoalrise so reduced frequency of action potential moving through AV node -> decrease HR and contractility
uses of beta blockers
tachycardia
atrial fibrillation
protective effect after MI
AE of beta blockers
bradycardia
hypotension -> decrease contractility if beta blockers block contractile portion of myocardium
MOA of calcium channel blocker
non dihydropridine calcium channel blockers: (primarily affect myocardium)(IV)
diltiazem
verapamil
block calcium entry into cell -> decrease slope of 4 and 0 in AV node
block atrial signals from processing through AV node and into ventricles
- prolonged ERP and APD (prolong both depol and repol)
use of calcium channel blockers
supraventricular tachycardia
hypertension
angina
AE of calcium channel blockers
hypotention
contraindicated: pre-existing depressed cardiac output -> further inhibit AV nodal conduction